PAVmed Inc. (NASDAQ:PAVM) has scheduled a conference call for 18th August 2020 at 4:30 PM Eastern Time to announce its 2Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.pavmed.com
Earnings Expectation
PAVmed Inc. is reporting second quarter earnings results on Tuesday 18th August 2020, before market open. The consensus estimates from Thomson Reuters are loss of $ 0.1 per share from $ 0.25 million in revenue. For the full year, analysts predict revenues of $ 1.00 million, while looking forward to loss of $ 0.4 per share.
PAVmed Inc. operates as a medical device company in the United States. The companys lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube.
